Champignon Brands (SHRMF)
$0.57 0.00 (0.00%)
15:59 EST SHRMF Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 55.37M
PE Ratio -
Volume (Avg. Vol.)
Day's Range 0.57 - 0.57
52-Week Range 0.22 - 1.74
Dividend & Yield N/A (N/A)
SHRMF Stock Predictions, Articles, and Champignon Brands News
- From InvestorPlace
- From the Web
Penny stocks are wildly dangerous and not meant for risk-averse investors. Still, if you want to play, here are some ideas.
These psychedelic stocks are worth accumulating on corrections. The companies are holding clinical trials for mental health drugs.
If you have a stack of Benjamins lying around and collecting dust, put them to good use with these stocks to buy with $5,000.
Psychedelic stocks are going to surge as the once "hardcore" group of pschedelic drugs gains widespread mainstream medicinal acceptance.
These psychedelic stocks have done extremely well despite the novel coronavirus pandemic and are set for major gains in the new normal.
Psychedelic stocks aren't cannabis level mainstream yet, but there's potential here as acceptance increases.
No one should ever bet on OTC stocks without serious consideration about their risk profile. However, if you know what you’re getting involved in, this much-maligned sector could offer a path to significant growth.
Psychedelics are losing their negative stigma, and the Shroom Boom is coming. To play that boom, consider these psychedelic stocks to buy.
While the coronavirus pandemic is thankfully fading in magnitude, the changes it has caused may stay with us for a long time. Here are nine growth stocks that can likely advantage the new normal.
Young investors can leverage their extra time to bet on high-growth stocks that are likely to jump on developing trends.
Psychedelic stocks are still small and not getting much attention, but those could actually positive traits for prescient investors.
Due to the devastation of the coronavirus, cheap stocks are a dime a dozen. However, these nine ideas may offer significant upside.